Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,144 public trials 2,036 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement

NCT06594432

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Hematological Department, People's Hospital of Jiangsu Province Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

NCT06573645

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

NCT06573151

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Real-World Study on Extranodal Lymphoma

NCT06573099

Conditions: Diffuse Large B Cell Lymphoma, Extranodal Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia

NCT06559644

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not yet recruiting

A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma

NCT06548347

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL

NCT06516978

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Astragalus for Symptomatic Alleviation in High-grade Lymphoma

NCT06510530

Conditions: Hemic and Lymphatic Diseases, High-grade Lymphoma, Immune System Diseases, +7 more
Locations: Bnai Zion Medical Center Haifa, Israel

View Trial Details

Not yet recruiting

A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

NCT06500507

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not yet recruiting

Bleeding in Multiple Myeloma

NCT06482931

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions